Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066452509> ?p ?o ?g. }
- W2066452509 endingPage "115" @default.
- W2066452509 startingPage "107" @default.
- W2066452509 abstract "The prevalence of type 2 diabetes mellitus (T2DM) among elderly people is increasing. Often associated with disabilities/comorbidities, T2DM lowers the chances of successful aging and is independently associated with frailty and an increased risk of hypoglycaemia, which can be further exacerbated by antihyperglycaemic treatment. From this perspective, the clinical management of T2DM in the elderly is challenging and requires individualization of optimum glycaemic targets depending on comorbidities, cognitive functioning and ability to recognize and self-manage the disease. The lack of solid evidence-based medicine supporting treatment guidelines for older people with diabetes further complicates the matter. Several classes of medicine for the treatment of T2DM are currently available and different drug combinations are often required to achieve individualized glycaemic goals. Many of these drugs, however, carry disadvantages such as the propensity to cause weight gain or hypoglycaemia. Dipeptidyl peptidase-4 (DPP-4) inhibitors, a recent addition to the pharmacological armamentarium, have become widely accepted in clinical practice because of their efficacy, low risk of hypoglycaemia, neutral effect on body weight, and apparently greater safety in patients with kidney failure. Although more information is needed to reach definitive conclusions, growing evidence suggests that DPP-4 inhibitors may become a valuable component in the pharmacological management of elderly people with T2DM. The present review aims to delineate the potential advantages of this pharmacological approach in the treatment of elderly people with T2DM." @default.
- W2066452509 created "2016-06-24" @default.
- W2066452509 creator A5027455344 @default.
- W2066452509 creator A5034383160 @default.
- W2066452509 creator A5079605815 @default.
- W2066452509 creator A5086131112 @default.
- W2066452509 date "2014-06-25" @default.
- W2066452509 modified "2023-10-18" @default.
- W2066452509 title "Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes" @default.
- W2066452509 cites W143230738 @default.
- W2066452509 cites W1569365382 @default.
- W2066452509 cites W1945958962 @default.
- W2066452509 cites W1966379378 @default.
- W2066452509 cites W1972565816 @default.
- W2066452509 cites W1976304072 @default.
- W2066452509 cites W1976425553 @default.
- W2066452509 cites W1977366782 @default.
- W2066452509 cites W1980054867 @default.
- W2066452509 cites W1986568472 @default.
- W2066452509 cites W1993533355 @default.
- W2066452509 cites W1994999755 @default.
- W2066452509 cites W2006247067 @default.
- W2066452509 cites W2007973246 @default.
- W2066452509 cites W2011581267 @default.
- W2066452509 cites W2015544031 @default.
- W2066452509 cites W2021446295 @default.
- W2066452509 cites W2022936370 @default.
- W2066452509 cites W2028603630 @default.
- W2066452509 cites W2030609731 @default.
- W2066452509 cites W2030852056 @default.
- W2066452509 cites W2035820774 @default.
- W2066452509 cites W2043226477 @default.
- W2066452509 cites W2045321591 @default.
- W2066452509 cites W2047844897 @default.
- W2066452509 cites W2056802309 @default.
- W2066452509 cites W2057397568 @default.
- W2066452509 cites W2058831278 @default.
- W2066452509 cites W2059534220 @default.
- W2066452509 cites W2062321935 @default.
- W2066452509 cites W2064130493 @default.
- W2066452509 cites W2072239150 @default.
- W2066452509 cites W2072836605 @default.
- W2066452509 cites W2075182875 @default.
- W2066452509 cites W2082460440 @default.
- W2066452509 cites W2083220058 @default.
- W2066452509 cites W2084744936 @default.
- W2066452509 cites W2085546759 @default.
- W2066452509 cites W2085621596 @default.
- W2066452509 cites W2087188973 @default.
- W2066452509 cites W2091977092 @default.
- W2066452509 cites W2092287139 @default.
- W2066452509 cites W2095738201 @default.
- W2066452509 cites W2096778151 @default.
- W2066452509 cites W2097995302 @default.
- W2066452509 cites W2098292453 @default.
- W2066452509 cites W2098361646 @default.
- W2066452509 cites W2100987099 @default.
- W2066452509 cites W2101017565 @default.
- W2066452509 cites W2104113021 @default.
- W2066452509 cites W2107222124 @default.
- W2066452509 cites W2113565490 @default.
- W2066452509 cites W2114437291 @default.
- W2066452509 cites W2115271679 @default.
- W2066452509 cites W2115932722 @default.
- W2066452509 cites W2116616880 @default.
- W2066452509 cites W2117762041 @default.
- W2066452509 cites W2118402327 @default.
- W2066452509 cites W2118669252 @default.
- W2066452509 cites W2118681878 @default.
- W2066452509 cites W2120774442 @default.
- W2066452509 cites W2125220286 @default.
- W2066452509 cites W2127854619 @default.
- W2066452509 cites W2129064931 @default.
- W2066452509 cites W2131830909 @default.
- W2066452509 cites W2135092775 @default.
- W2066452509 cites W2137138384 @default.
- W2066452509 cites W2138263417 @default.
- W2066452509 cites W2138835437 @default.
- W2066452509 cites W2140134367 @default.
- W2066452509 cites W2142514031 @default.
- W2066452509 cites W2144610870 @default.
- W2066452509 cites W2145004264 @default.
- W2066452509 cites W2146309429 @default.
- W2066452509 cites W2149971684 @default.
- W2066452509 cites W2150069603 @default.
- W2066452509 cites W2150180487 @default.
- W2066452509 cites W2151848850 @default.
- W2066452509 cites W2153957843 @default.
- W2066452509 cites W2158498099 @default.
- W2066452509 cites W2158927982 @default.
- W2066452509 cites W2163051634 @default.
- W2066452509 cites W2165449026 @default.
- W2066452509 cites W2165783452 @default.
- W2066452509 cites W2171646682 @default.
- W2066452509 cites W2406255324 @default.
- W2066452509 doi "https://doi.org/10.1111/dom.12319" @default.
- W2066452509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24867662" @default.
- W2066452509 hasPublicationYear "2014" @default.